Proapoptotic miltefosine nanovesicles show synergism with paclitaxel: Implications for glioblastoma multiforme therapy.

Abstract

Hexadecylphosphocholine (HePC) or miltefosine based proapoptotic lipid nanovesicles encapsulating paclitaxel for synergistic anticancer effect of paclitaxel and miltefosine in chemoresistant human glioblastoma multiforme (U-87 MG) overexpressing multidrug resistance 1 (MDR1) gene product P-glycoprotein (P-gp), were developed in this study. The nanovesicles… (More)
DOI: 10.1016/j.canlet.2012.08.022

Topics

12 Figures and Tables

Cite this paper

@article{Thakur2013ProapoptoticMN, title={Proapoptotic miltefosine nanovesicles show synergism with paclitaxel: Implications for glioblastoma multiforme therapy.}, author={Ankita Pramod Thakur and Nitin S Joshi and Thanigaivel Shanmugam and Rinti Banerjee}, journal={Cancer letters}, year={2013}, volume={334 2}, pages={274-83} }